Fiera Capital (Canada)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-622,953
| Closed | -$51.3M | – | 461 |
|
|
2024
Q2 | $51.3M | Buy |
622,953
+7,009
| +1% | +$584K | 0.16% | 95 |
|
|
2024
Q1 | $53.8M | Sell |
615,944
-38,923
| -6% | -$3.48M | 0.16% | 97 |
|
|
2023
Q4 | $63.1M | Buy |
654,867
+6,326
| +1% | +$560K | 0.19% | 73 |
|
|
2023
Q3 | $57.4M | Buy |
648,541
+206,012
| +47% | +$18.3M | 0.18% | 68 |
|
|
2023
Q2 | $38.4M | Sell |
442,529
-8,065
| -2% | -$759K | 0.11% | 106 |
|
|
2023
Q1 | $43.8M | Sell |
450,594
-10,514
| -2% | -$1.09M | 0.13% | 87 |
|
|
2022
Q4 | $47.7M | Sell |
461,108
-254
| -0.1% | -$23.8K | 0.15% | 75 |
|
|
2022
Q3 | $36.9M | Sell |
461,362
-4,192
| -0.9% | -$373K | 0.13% | 89 |
|
|
2022
Q2 | $38.6M | Sell |
465,554
-11,428
| -2% | -$910K | 0.11% | 92 |
|
|
2022
Q1 | $36.8M | Buy |
476,982
+423,444
| +791% | +$35.4M | 0.1% | 122 |
|
|
2021
Q4 | $4.73M | Buy |
53,538
+295
| +0.6% | +$24.3K | 0.01% | 210 |
|
|
2021
Q3 | $4.12M | Sell |
53,243
-619,183
| -92% | -$48.9M | 0.01% | 210 |
|
|
2021
Q2 | $56.1M | Sell |
672,426
-22,736
| -3% | -$1.8M | 0.14% | 91 |
|
|
2021
Q1 | $52.5M | Sell |
695,162
-11,810
| -2% | -$965K | 0.15% | 86 |
|
|
2020
Q4 | $62M | Sell |
706,972
-2,297
| -0.3% | -$182K | 0.17% | 82 |
|
|
2020
Q3 | $54M | Buy |
709,269
+215,865
| +44% | +$21.8M | 0.16% | 81 |
|
|
2020
Q2 | $60.9M | Sell |
493,404
-1,744
| -0.4% | -$173K | 0.21% | 68 |
|
|
2020
Q1 | $41.8M | Buy |
495,148
+112,035
| +29% | +$9.65M | 0.17% | 77 |
|
|
2019
Q4 | $32.4M | Sell |
383,113
-21,761
| -5% | -$1.64M | 0.11% | 131 |
|
|
2019
Q3 | $27.3M | Buy |
404,874
+385,861
| +2,029% | +$29.7M | 0.1% | 143 |
|
|
2019
Q2 | $1.63M | Buy |
19,013
+5,538
| +41% | +$474K | 0.01% | 403 |
|
|
2019
Q1 | $1.2M | Buy |
13,475
+3,584
| +36% | +$332K | ﹤0.01% | 450 |
|
|
2018
Q4 | $842K | Buy |
9,891
+1,747
| +21% | +$166K | ﹤0.01% | 476 |
|
|
2018
Q3 | $789K | Buy |
8,144
+3,127
| +62% | +$312K | ﹤0.01% | 507 |
|
|
2018
Q2 | $473K | Buy |
5,017
+861
| +21% | +$75.4K | ﹤0.01% | 559 |
|
|
2018
Q1 | $337K | Buy |
4,156
+1,731
| +71% | +$149K | ﹤0.01% | 561 |
|
|
2017
Q4 | $216K | Sell |
2,425
-80
| -3% | -$6.96K | ﹤0.01% | 597 |
|
|
2017
Q3 | $233K | Sell |
2,505
-4,108
| -62% | -$363K | ﹤0.01% | 589 |
|
|
2017
Q2 | $601K | Buy |
6,613
+101
| +2% | +$9.19K | ﹤0.01% | 491 |
|
|
2017
Q1 | $572K | Buy |
6,512
+142
| +2% | +$12.6K | ﹤0.01% | 495 |
|
|
2016
Q4 | $528K | Sell |
6,370
-886
| -12% | -$76.2K | ﹤0.01% | 643 |
|
|
2016
Q3 | $671K | Sell |
7,256
-48
| -0.7% | -$4.52K | ﹤0.01% | 573 |
|
|
2016
Q2 | $568K | Buy |
+7,304
| New | +$621K | ﹤0.01% | 640 |
|
Other funds holding BMRN
EIM